NASDAQ:ABCL AbCellera Biologics Inc.

Healthcare / Biotech · Lifecycle: Clinical Stage

All signal reports for this ticker, newest first.

• April 9, 2026Latest

  ABCL_Signal_v5_20260409_0938.html  ·  Q:67 V:78 T:55 D:70  ·  Short HOLD · Medium BUY · Long BUY  ·  $3.41
  View Report →